Fed Hikes Interest Rates, Signals Another: 4 Low-Beta Defensive Picks

Fed hikes rates and signals another, putting MGEE, ADM, DOLE and DGX in focus as low-beta defensive picks.

Zacks Investment Research • Sep 17, 2026

Nine in 10 Voters Express Concern That Medicare Lab Payment Cuts Will Harm Patient Access to Diagnostic Lab Testing, Finds National Survey from Quest Diagnostics

75% of registered voters surveyed call diagnostic testing "very important" to their care, and a  bipartisan majority wants Congress to pass the RESULTS Act before additional Medicare cuts are scheduled to take effect January 2027 SECAUCUS, N.J., Sept. 16, 2026 /PRNewswire/ -- A new national survey finds the overwhelming majority of American voters rely on diagnostic laboratory testing to guide their healthcare decisions and are deeply concerned about scheduled Medicare payment cuts that could put that access at risk.

PRNewsWire • Sep 16, 2026

Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?

Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Investment Research • Sep 16, 2026

Quest Diagnostics Incorporated (DGX) Presents at 2026 Global Healthcare Conference Transcript

Quest Diagnostics Incorporated (DGX) Presents at 2026 Global Healthcare Conference Transcript

Seeking Alpha • Sep 15, 2026

Quest Diagnostics Incorporated (DGX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Quest Diagnostics Incorporated (DGX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Seeking Alpha • Sep 14, 2026

Quest Diagnostics (DGX) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Sep 14, 2026

Apple Health app Users to be Able to Order Labs from Quest Diagnostics

Coming later this year, Apple Health app users will be able to conveniently and securely purchase and receive results of Quest's biomarker lab testing directly in the app SECAUCUS, N.J., Sept. 9, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) today announced that Apple Health app users in the United States1 will be able to conveniently purchase a tailored Quest laboratory test panel that includes over 50 biomarkers directly through the app on iPhone and iPad later this year.

PRNewsWire • Sep 9, 2026

Quest Diagnostics CEO Sells 10,000 Shares for $2.4 Million

The transaction involved 10,000 shares with an estimated value of ~$2.4 million based on the execution price on September 1, 2026. The shares traded represent 8% of the equity stake held directly by the executive prior to this filing.

The Motley Fool • Sep 8, 2026

Take the Zacks Approach to Beat the Markets: Oportun Financial, Uranium Royalty & Amgen in Focus

Zacks spotlights Oportun Financial, Uranium Royalty and Amgen, alongside standout gains from its key stock portfolios.

Zacks Investment Research • Sep 8, 2026

Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Aug 31, 2026